Francis Biomechanics Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-13

Study Completion Date

2018-08-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the effect of a range of pre-formed orthoses on function of the foot and leg to generate technical data on how the individual insoles impact gait, distribution of load and stability in a healthy population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of a Newly Developed Brace on Foot Biomechanics.

NCT05819567

Healthy

UNKNOWN NA

An Evaluation Of Healthy Ankle Motion And Morphology

NCT03619382

Healthy Ankle

COMPLETED

Early Protected Full Weight-bearing vs. Partial Weight-bearing After Surgical Fixation of Unstable Ankle Fractures, Monitored With Bio-feedback Insoles.

NCT06023979

Post Operative Treatment After Unstable Malleolar Fractures

NOT_YET_RECRUITING NA

Villency-Proof of Action: Foot Device, Balance and Sway, Kinematics of Walking

NCT03663816

Balance

COMPLETED NA

Biomechanical Analysis of Gait

NCT07140159

Biomechanical Assessment of the Foot During Gait

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Subject

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Insoles

Orthotic Insoles

Intervention Type DEVICE

Standard shoe

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Non-Investigational product

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Healthy male and female subjects between the ages of 18-60 years inclusive.
2. Subjects who are able to give written informed consent.
3. Subjects who are able to understand the study, cooperate with the study procedures and are able to attend all study assessments.
4. Subjects who are willing to wear a t-shirt and shorts during the study assessments.
5. Subjects who are willing and able to stand for a minimum of two hours at a time during the study assessments.
6. Subject with shoe size between 4.5 to 11 (UK) / 37 to 45 (European).
7. Subjects who can achieve the acceptable fit of standard shoes.
8. Subjects who do not have any walking impairments and can walk without distress. This will be determined through walking at a speed of 3-5 kmph for a distance of 30 m.
9. Subjects with a Foot Posture Index (FPI) between 6 and 9 showing mild pronation as determined by the study Investigator or designees.
10. Subjects with a BMI between 18.5 - 24.9 kg/m2.

Exclusion Criteria

1. Subjects who are pregnant or who have given birth within the last 6 months.
2. Subjects who have a medical condition that could compromise the use of the orthotic insoles (peripheral vascular disease or sensory neuropathy).
3. Subjects that have Leg Length Discrepancy (LLD) of more than 5 mm. This will be determined using the Downings Sign (7), a test which is used to establish actual versus functional LLD. This will be cross-referenced with anatomical land marks.
4. Subjects that use prescribed or self-administrated orthotics to correct biomechanical or other issues.
5. Subject that have received any previous orthotic treatment.
6. Subjects who have a current or previous injury that has prevented their usual activities for more than 3 weeks in the last year.
7. Subjects with history of lower limb or foot surgery, inflammatory disease, neurological disease, diabetes, leg ulceration, skin grafts or any other condition that in the opinion of the Investigator or designees could interfere with the assessments in this study.
8. Subjects having ischemia or poor blood supply to the feet, Charcot Arthropathy, autoimmune disease (e.g. rheumatoid arthritis) and connective tissue disease (e.g. scleroderma).
9. Subjects demonstrating symptoms of macrovascular diseases (e.g. angina, stroke).
10. Individuals suffering from other conditions affecting the feet, such as infectious foot conditions, which in the opinion of the Investigator or designees, would interfere with the generation of data and risk the spread of infection to other subjects through the use of the standard shoe.
11. Individuals with broken/irritated or damaged skin on their feet.
12. Individuals suffering from relevant product allergies or sensitivities.
13. Individuals who have consulted a healthcare professional for a gait related or foot pain issue.
14. Individuals who were previously in another clinical study within the last 3 months prior to screening assessment.
15. Employees who are directly involved with the study at study site.
16. Any partner or first degree relative of anyone that has a role in the study at the CRO/Site/Sponsor.

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes